American Bio Medica Corporation, a US-based manufacturer of accurate, cost-effective immunoassay test kits, announced that it has submitted to the Securities and Exchange Commission a Notification of Late Filing with respect to the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.
March 31, 2021
· 2 min read
